Pathomics Health is excited to announce our partnership with Inspire Healthcare! Under the collaboration, Inspire Healthcare will license and commercialize our Pathgene Neurological series – DNA profiling for neurological diseases such as dementia, ADHD, Alzheimer’s, and Parkinson’s disease.
Beyond commercialising, Inspire Healthcare will be integrating the DNA profiling outcome into their upcoming prognosis product, a first-of-its-kind innovation in the market. To further enhance the health management experience, the entire patient journey will be handled by our latest proprietary P7 platform to provide a holistic earlier insights, earlier intervention, better disease management, and improved patient outcomes.
Exciting journey ahead!!!
